宜昌東陽光長江藥業股份有限公司 - H股 01558Stock Information

Stock Information · Old Rules
// Company Overview //
Stock Name宜昌東陽光長江藥業股份有限公司 - H股
Stock Code01558
Company Full Name宜昌東陽光長江藥業股份有限公司 - H股
Industry醫療保健
Principal Activities主要於中國從事藥品生產及銷售。
Listing Date2015-12-29
Listing Rules EraOld Rules
Listing Rules ChapterNo data
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國湖北省宜昌宜都市濱江路38號
Business Address (Hong Kong)No data
Place of IncorporationNo data
Listing MethodNo data
Listing BoardMain Board
Websitehttp://www.hec-changjiang.com
Share Registrar香港中央證券登記有限公司
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
// Offering Information //
Prospectus Date2015-12-15
Offer PriceHK$ 15.00 / shares
Total Funds RaisedHK$ 135,198,000
// Valuation & Financials //
Market Cap (at Offer Price)HK$ 0
// First Day Performance
First Day CloseLoading...
First Day OpenHK$ 15.0
First Day Change-3.07%
First Day Volume16172600.0
First Day Turnover238113000.0
// Price Chart //
Loading...
// Use of Proceeds
Use of Proceeds1、約44.8%所得款項凈額,或約605.6百萬港元(人民幣500百萬元),用于在宜都基地三號地興建新口服制劑生產工廠; 2、約12.6%所得款項凈額,或約170.2百萬港元(人民幣140.5百萬元),用于在宜都基地三號地興建新胰島素生產工廠; 3、約28.2%所得款項凈額,或約354.1百萬港元(人民幣292.3百萬元),用于現有及未來產品的推廣及營銷活動,包括學術推廣、廣告及贊助、出版營銷及推廣數據、擴充及建立專門針對我們產品的隊伍以及對我們的產品進行市場調研; 4、約10%所得款項凈額,或約125.6百萬港元(人民幣103.7百萬元)將用作營運資金及一般企業用途。
// Underwriting Syndicate //
独家保荐人 (1)
中国国际金融香港证券有限公司
整体协调人 (3)
中国国际金融香港证券有限公司 工商国际金融有限公司 招银国际融资有限公司
联席账簿管理人 (6)
中国国际金融香港证券有限公司 工商国际金融有限公司 招银国际融资有限公司 农银国际融资有限公司 建银国际金融有限公司 野村国际(香港)有限公司
联席牵头经办人 (6)
中国国际金融香港证券有限公司 工商国际金融有限公司 招银国际融资有限公司 农银国际融资有限公司 建银国际金融有限公司 野村国际(香港)有限公司
// Cornerstone Investors //
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Ally Bridge LB-Sunshine Limited 139,680,000 HKD 2.10% 6 months 2016-06-29
2 保银资产管理有限公司 170,520,000 HKD 2.50% 6 months 2016-06-29
3 南方龙腾基金 77,514,000 HKD 1.10% 6 months 2016-06-29
4 三星电气(香港)有限公司 232,545,000 HKD 3.40% 6 months 2016-06-29
// Directors & Management //
Chairman唐新發
Company Secretary彭琪云;黃偉超
No director data available.
// Major Shareholders //
Major Shareholders & Holdings廣東東陽光藥業有限公司(51.4%);毛杰(18.35%)
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics